These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35922577)

  • 1. Environmental Monitoring for Closed Robotic Workcells Used in Aseptic Processing: Data to Support Advanced Environmental Monitoring Strategies.
    McCall J; Barnard N; Gadient K; Kasireddy C; Kurtz A; Li Y; Page T; Putnam T; Brennan Á
    AAPS PharmSciTech; 2022 Aug; 23(6):215. PubMed ID: 35922577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk analysis of sterile production plants: a new and simple, workable approach.
    Gapp G; Holzknecht P
    PDA J Pharm Sci Technol; 2011; 65(3):217-26. PubMed ID: 22293233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the BioVigilant IMD-A, a novel optical spectroscopy technology for the continuous and real-time environmental monitoring of viable and nonviable particles. Part II. Case studies in environmental monitoring during aseptic filling, intervention assessments, and glove integrity testing in manufacturing isolators.
    Miller MJ; Walsh MR; Shrake JL; Dukes RE; Hill DB
    PDA J Pharm Sci Technol; 2009; 63(3):259-83. PubMed ID: 20069799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes.
    Krämer I; Federici M; Kaiser V; Thiesen J
    J Oncol Pharm Pract; 2016 Apr; 22(2):195-204. PubMed ID: 25549919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH; Franssen EJF; Pilesi F; Crul M
    Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Environmental Monitoring for Closed Robotic Workcells Used in Aseptic Processing: Data to Support Advanced Environmental Monitoring Strategies.
    McCall J; Barnard N; Gadient K; Kasireddy C; Kurtz A; Li Y; Page T; Putnam T; Brennan Á
    AAPS PharmSciTech; 2022 Aug; 23(7):245. PubMed ID: 36042059
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing.
    Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D
    PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological controls of aseptic handling in Dutch hospital pharmacies: Results, limits, and methods for assessing.
    Boom FA; Le Brun PPH; Bühringer S; Sirks M; Touw DJ
    Eur J Pharm Sci; 2022 Aug; 175():106228. PubMed ID: 35640785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological monitoring during aseptic handling: Methods, limits and interpretation of results.
    Boom FA; Brun PPHL; Bühringer S; Touw DJ
    Eur J Pharm Sci; 2020 Dec; 155():105540. PubMed ID: 32898638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Study on Incubation Conditions for Environmental Monitoring and Aseptic Process Simulation.
    Guinet R; Berthoumieu N; Dutot P; Triquet J; Ratajczak M; Thibaudon M; Bechaud P; Arliaud C; Miclet E; Giordano F; Larcon M; Arthaud C
    PDA J Pharm Sci Technol; 2017 1/2; 71(1):43-49. PubMed ID: 27593691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method.
    Feutry F; Simon N; Genay S; Lannoy D; Barthélémy C; Décaudin B; Labalette P; Odou P
    Drug Dev Ind Pharm; 2016 Jan; 42(1):166-174. PubMed ID: 26006333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vapor Phase Hydrogen Peroxide Decontamination or Sanitization of an Isolator for Aseptic Filling of Monoclonal Antibody Drug Product-Hydrogen Peroxide Uptake and Impact on Protein Quality.
    Hubbard A; Roedl T; Hui A; Knueppel S; Eppler K; Lehnert S; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(4):348-366. PubMed ID: 29545321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions Risk Evaluation and Management in Aseptic Manufacturing.
    Baseman H; Chakraborty S; Long MA
    PDA J Pharm Sci Technol; 2022; 76(6):485-496. PubMed ID: 35613741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass extraction container closure integrity physical testing method development for parenteral container closure systems.
    Yoon SY; Sagi H; Goldhammer C; Li L
    PDA J Pharm Sci Technol; 2012; 66(5):403-19. PubMed ID: 23035025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotics and Aseptic Processing in View of Regulatory Requirements.
    Tanzini A; Ruggeri M; Bianchi E; Valentino C; Vigani B; Ferrari F; Rossi S; Giberti H; Sandri G
    Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug waste of ready-to-administer syringes in the intensive care unit: Aseptically prepared syringes versus prefilled sterilized syringes.
    van Gelder TG; Lalmohamed A; Dorst-Mooiman KD; Dekker JC; Schinkel MJ; Sikma MA; Uijtendaal EV; Egberts TCG
    Eur J Pharm Sci; 2023 Dec; 191():106590. PubMed ID: 37742987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring minimization of grade B environments based on risk assessment using three-dimensional airflow measurements and computer simulation.
    Katayama H; Higo T; Tokunaga Y; Katoh S; Hiyama Y; Morikawa K
    PDA J Pharm Sci Technol; 2008; 62(4):244-55. PubMed ID: 19174953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential application of quantitative microbiological risk assessment techniques to an aseptic-UHT process in the food industry.
    Pujol L; Albert I; Johnson NB; Membré JM
    Int J Food Microbiol; 2013 Apr; 162(3):283-96. PubMed ID: 23454820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.